U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06872372) titled 'Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure' on Feb. 27.
Brief Summary: Acute liver failure (ALF) is a serious condition in which the liver suddenly stops working, often leading to life-threatening complications. While N-Acetylcysteine (NAC) is widely used to treat ALF caused by acetaminophen overdose, its benefits in ALF due to other causes, such as viral infections or drug reactions, remain uncertain.
This study is a randomized controlled trial designed to investigate whether NAC can improve survival rates and reduce hospital stays in patients with non-acetaminophen-induced ALF. Participants will be...